Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
WorkCompWire
Article
WorkCompWire: Ensuring Seamless Ancillary Services for Catastrophic Claims
By Carlos Cordova, Director of Operations, Priority Care Solutions, a division of Genex Services
Workers' Comp
News Release
Risk & Insurance: Top 10 Lessons Learned in Helping Workers Move Past COVID-19
Here are the top lessons workers' comp pros have learned about COVID-19, its impact on the workplace and on how to help employees get back to
Mitchell
Virtual Event
2021 Regulatory Predictions for Auto Casualty and Workers’ Comp [Podcast]
On-Demand
In 2020, the workers' compensation and auto casualty regulatory environment was more active than ever—since the start of the COVID-19 pandemic, U.S
Workers' Comp
News Release
Business Insurance: Wearables sound alarm on coronavirus
Technology that can alert a manufacturing worker of a forklift operating nearby or a construction worker that there's a fall risk is being de
Mitchell
News Release
New Presumption Laws Signed: California and New Jersey
On September 14, 2020, New Jersey Governor Phil Murphy signed SB 2380 into law.
Mitchell
News Release
White House Issues Executive Order on Drug Pricing
On September 13, 2020, President Trump signed an executive order intended to lower drug prices in the United States.